Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 521

Similar articles for PubMed (Select 18589448)

1.

Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus.

Chase HP, Arslanian S, White NH, Tamborlane WV.

J Pediatr. 2008 Oct;153(4):547-53. doi: 10.1016/j.jpeds.2008.04.063. Epub 2008 Jun 27.

PMID:
18589448
2.

Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes.

Bolli GB, Songini M, Trovati M, Del Prato S, Ghirlanda G, Cordera R, Trevisan R, Riccardi G, Noacco C.

Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):571-9. doi: 10.1016/j.numecd.2008.05.003. Epub 2008 Aug 3.

PMID:
18676131
3.

Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes.

Garg SK, Paul JM, Karsten JI, Menditto L, Gottlieb PA.

Diabetes Technol Ther. 2004 Oct;6(5):589-95.

PMID:
15628812
5.

[Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy].

Pesić M, Zivić S, Radenković S, Velojić M, Dimić D, Antić S.

Vojnosanit Pregl. 2007 Apr;64(4):247-52. Serbian.

PMID:
17580534
7.

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.

Clin Ther. 2008 Aug;30(8):1476-84. doi: 10.1016/j.clinthera.2008.08.013.

PMID:
18803989
8.

Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin.

Chase HP, Dixon B, Pearson J, Fiallo-Scharer R, Walravens P, Klingensmith G, Rewers M, Garg SK.

J Pediatr. 2003 Dec;143(6):737-40.

PMID:
14657818
9.

Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus.

Schober E, Schoenle E, Van Dyk J, Wernicke-Panten K; Pediatric Study Group of Insulin Glargine.

J Pediatr Endocrinol Metab. 2002 Apr;15(4):369-76.

PMID:
12008682
10.

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

Clin Ther. 2004 Apr;26(4):502-10.

PMID:
15189747
11.
13.

Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.

Murphy NP, Keane SM, Ong KK, Ford-Adams M, Edge JA, Acerini CL, Dunger DB.

Diabetes Care. 2003 Mar;26(3):799-804.

PMID:
12610040
14.

A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.

Hassan K, Rodriguez LM, Johnson SE, Tadlock S, Heptulla RA.

Pediatrics. 2008 Mar;121(3):e466-72. doi: 10.1542/peds.2007-1679. Epub 2008 Feb 25.

16.

Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

Rosenstock J, Park G, Zimmerman J; U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

Diabetes Care. 2000 Aug;23(8):1137-42.

18.

A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes.

Home PD, Rosskamp R, Forjanic-Klapproth J, Dressler A; European Insulin Glargine Study Group.

Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):545-53.

PMID:
16021649
19.

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.

Rosenstock J, Fonseca V, McGill JB, Riddle M, Hallé JP, Hramiak I, Johnston P, Davis M.

Diabetologia. 2009 Sep;52(9):1778-88. doi: 10.1007/s00125-009-1415-7. Epub 2009 Jun 13.

20.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk